Skip to main content
SpringerLink
Log in

Pathologie der Skelettmuskulatur

  • Chapter
Pathologie

Zusammenfassung

Die Diagnostik der Skelettmuskelerkrankungen hat in den letzten 10-20 Jahren außerordentliche Fortschritte erfahren, die vor all em auf die Entwicklung neuer Methoden in der Histochemie. Immunhistochemie, Zytochemie, Biochemie und Elektronenmikroskopie zurückzuführen sind.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 54.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 69.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Adams RD (1975) Diseases of muscle. A study in pathology. 3rd edn. Harper & Row. New York

    Google Scholar 

  2. Becker PE (1964) Myopathien. In: Becker PE (Hrsg) Humangenetik. Ein kurzes Handbuch in 5 Bänden. Bd II/1. Thieme. Stuttgart. S 411–550

    Google Scholar 

  3. Bethlem J (1980) Myopathies. 2nd edn. North Holland. Amsterdam New York Oxford

    Google Scholar 

  4. Carpenter S., Karpati G (1984) Pathology of skeletal muscle. Churchill Livingstone. New York

    Google Scholar 

  5. Dubowitz V (1985) Muscle Biopsy. A practical approach. 2nd edn. Tindall. London

    Google Scholar 

  6. Dubowitz V, Brooke MH (1973) Muscle biopsy: A modern approach. Vol 2 in The Series. Saunders. London Philadelphia Toronto (Major problems in neurology. vol 2)

    Google Scholar 

  7. Engel AG., Franzini-Armstrong C (1994) Myology. Basic and Clinical. 2nd edn. McGraw-HilL New York

    Google Scholar 

  8. Jerusalem F., Zierz S (1991) Muskelerkrankungen. Klinik. Therapie. Pathologie. 2. AufL Thieme. Stuttgart

    Google Scholar 

  9. Kakulas BA., Adams RD (1985) Disease of muscle. Pathological foundations of clinical myologv. Harper & Row. Philadelphia Cambridge New York London

    Google Scholar 

  10. Mastaglia FL., Walton SJ (1992) (eds) Skeletal muscle pathology. 2nd edn. Churchill Livingstone. Edinburgh London Melbourne New York

    Google Scholar 

  11. Schröder JM (1982) Pathologie der Muskulatur. Springer. Berlin Heidelberg New York (Spezielle pathologische Anatomie. Bd 15)

    Google Scholar 

  12. Swash M, Schwartz MS (1988) Neuromuscular diseases. A practical approach to diagnosis and management. 2nd edn. Springer. Berlin Heidelberg New York

    Google Scholar 

  13. Vinken PJ, Bruyn GW, Klawans HL (eds) (1992) Myopathies. In: Handbook of Clinical Neurology. Vol. 62. Revised Series 18. 685 P

    Google Scholar 

  14. Walton IN (1988) Disorders of voluntary muscle. 5th edn. Churchill Livingstone. Edinburgh London

    Google Scholar 

  15. Banker BQ, Przybylski RJ, van der Meulen JP (1972) Research in muscle development and the muscle spindle. Intern Congr. Series No.240. Excerpta Medica, Amsterdam London Princeton

    Google Scholar 

  16. Barohn RJ, Jackson CE, Rogers SJ, Ridings LW, McVey AL (1994) Prolonged paralysis due to nondepolarizing neuromuscular blocking agents and corticosteroids. Muscle & Nerve 17: 647–654

    CAS  Google Scholar 

  17. Massa R, Carpenter S, Holland P, Karpati G (1992) Loss and renewal of thick myofilaments in glucocorticoid-treated rat soleus after denervation and reinnervation. Muscle Nerve 15: 1290–1298

    PubMed  CAS  Google Scholar 

  18. Lane RJM, Mastaglia FL (1978) Drug-induced myopathies in man. Lancet 3: 562–565

    Google Scholar 

  19. Barohn RJ, Jackson CE, Rogers SJ, Ridings LW, McVey AL (1994) Prolonged paralysis due to nondepolarizing neuromuscular blocking agents and corticosteroids. Muscle & Nerve 17: 647–654

    CAS  Google Scholar 

  20. Massa R, Carpenter S, Holland P, Karpati G (1992) Loss and renewal of thick myofilaments in glucocorticoid-treated rat soleus after denervation and reinnervation. Muscle Nerve 15: 1290–1298

    PubMed  CAS  Google Scholar 

  21. Abraham WA (1977) Factors in delayed muscle soreness. Med Sci Sports 9: 11–20

    PubMed  CAS  Google Scholar 

  22. Al-Lozi MT, Pestronk A, Yee WC, Flaris N, Cooper J (1994). Rapidly evolving myopathy with myosin-deficient muscle fibers. Ann Neurol 35: 273–279

    CAS  Google Scholar 

  23. Banker BQ, Chester CS (1973) Infarction of thigh muscle in the diabetic patient. Neurology (Minneap) 23: 667–677

    CAS  Google Scholar 

  24. Bolthauser E (1976) Differentialdiagnose des Torticollis im Kindesalter. Schweiz Med Wochenschr 106: 1261–1264

    Google Scholar 

  25. Reznik M (1970) Satellite cells, myoblasts, and skeletal muscle regeneration. In: Mauro A, Shafiq SA, Milhorat AT, (eds) Intern Congr Series No 218. Excerpta Medica, Amsterdam, pp 133–153

    Google Scholar 

  26. Schmalbruch H (1976) Muscle fibre splitting and regeneration in diseased human muscle. Neuropathol Appl Neurobiol 2: 3–19

    Google Scholar 

  27. Schröder JM, Huffmann B, Braun Y, Richter H-P (1992) Spasmodic torticollis: severe compression neuropathy in rami dorsales of cervical nerves C 1–6. Acta Neuropathol 84: 416–424

    PubMed  Google Scholar 

  28. Shafiq SA (1970) Satellite cells and fiber nuclei in muscle regeneration. In: DiMauro A, Shafiq SA, Milhorat AT, (eds) Intern Congr Series No 218. Excerpta Medica, Amsterdam, pp 122–132

    Google Scholar 

  29. Teräväinen H (1977) Striated muscle ultrastructure in intermittent claudication. Arch Pathol Lab Med 101: 230–235

    PubMed  Google Scholar 

  30. Dieler R, Schroder JM (1990) Lacunar dilatations of intrafusal and extrafusal terminal cisternae, annulate lamellae, confronting cisternae and tubofilamentous inclusions within the spectrum of muscle and nerve fiber changes in myotonic dystrophy. Pathol Res Pract 186: 371–382

    PubMed  CAS  Google Scholar 

  31. Enzinger FM, Dulcey F (1967) Proliferative myositis. Report of 33 cases. Cancer 20: 2213

    PubMed  CAS  Google Scholar 

  32. Fidzianska A (1973) Virus-like structures in muscle in chronic polymyositis. Acta Neuropathol 23: 23–31

    PubMed  CAS  Google Scholar 

  33. Fukuhara N (1979) Electron microscopical demonstration of nucleic acids in virus-like particles in the skeletal muscle of a traffic accident victim. Acta Neuropathol 47: 55–59

    PubMed  CAS  Google Scholar 

  34. Gerber N (1978) Polymyalgia rheumatica. Ein Teilaspekt der Riesenzellarterätis. In: Ergebnisse der inneren Medizin und Kinderheilkunde. Springer, Berlin Heidelberg New York, S85–149

    Google Scholar 

  35. Haas C, Arnason GW (1974) Cell-mediated immunity in polymyositis. Creatine phosphokinase release from muscle cultures. Arch Neurol 31: 192–196

    PubMed  CAS  Google Scholar 

  36. Heffner RR, Armbrustmacher VW, Earle KM (1977) Focal myositis. Cancer 40: 301–306

    PubMed  Google Scholar 

  37. Heffner RR, Barron SA (1980) Denervating changes in focal myositis, a benign inflammatory pseudotumor. Arch Pathol Lab Med 104: 261–264

    PubMed  Google Scholar 

  38. Hewlett RH, Brownell B (1975) Granulomatous myopathy; its relationship to sarcoidosis and polymyositis. J Neurol Neurosurg Psychiatry 38: 1090–1099

    PubMed  CAS  Google Scholar 

  39. Hughes JT, Esiri MM (1975) Ultrastructural studies in human polymyositis, a benign inflammatory pseudotumor. Arch Pathol Lab Med 104: 261–264

    Google Scholar 

  40. Kakulas BA (1966) Destruction of differentiated muscle cultures by sensitized lymphoid cells. J Pathol Bacteriol 91: 495–503

    PubMed  CAS  Google Scholar 

  41. Kern WH (1960) Proliferative myositis: a pseudosarcomatous reaction to injury. Arch Pathol69: 209–216

    Google Scholar 

  42. Layzer RB, Shearn MA, Satya-Murti S (1977) Eosinophilic polymyositis. Ann Neurol 1: 65–71

    PubMed  CAS  Google Scholar 

  43. Love LA, Leff RL, Fraser DD, Targoff IN, Dalakas M, Plotz PH, Miller FW (1991) A new approach to the classification of idiopathic inflammatory myopathy: myositis-specific autoantibodies define useful homogeneous patient groups. Medicine 70: 360–374

    PubMed  CAS  Google Scholar 

  44. Matsubara S, Shima T, Takamori M (1993) Experimental allergic myositis in SJL/J mice immunized with rabbit myosin B fraction: immunohistochemical analysis and transfer. Acta Neuropathol 85:138–144

    PubMed  CAS  Google Scholar 

  45. Miller FW, Love LA, Barbieri SA, Balow JE, Plotz PH (1990) Lymphocyte activation markers in idiopathic myositis: changes with disease activity and differences among clinical and autoantibody subgroups. Clin Exp Immunol 81: 373–379

    PubMed  CAS  Google Scholar 

  46. Peter HH (1991) Vaskulitiden. In: Peter HH, (Hrsg) Klinische Immunologie. Urban & Schwarzenberg, Mänchen Wien Baltimore (Innere Medizin der Gegenwart, Bd 9. S 401–404)

    Google Scholar 

  47. SchrOder JM, Stein GW, Schulz A (1982) Zur Feinstruktur der eosinophilen Myositis. In: Fortschritte der Myologie, Bd VI. Gutenbergdruckerei, Freiburg/Br, S30–37

    Google Scholar 

  48. Schröder JM, Bertram M, Schnabel R, Pfaff U (1992) Nuclear and mitochondrial changes of muscle fibers in AIDS after treatment with high doses of zidovudine. Acta Neuropathol 85: 39–47

    Google Scholar 

  49. Stark RJ (1979) Eosinophilic polymyositis. Arch Neurol 36: 721–722

    PubMed  CAS  Google Scholar 

  50. Stiller D, Katenkamp D (1975) The subcutaneous fascial analogue of myositis proliferans. Electron microscopic examination of two cases and comparison with myositis ossificans localisata. Virchows Arch Path Anat Histol 368: 361–371

    CAS  Google Scholar 

  51. Stumpf J, Kaduk B, Undeutsch K, Landgraf H, Gofferje H (1978) Trichinose. Epidemiologie, Klinik und Diagnostik. Dtsch Med Wochenschr 103:1556–1562

    PubMed  CAS  Google Scholar 

  52. Wirman JA (1976) Nodular fascätis, a lesion of myofibroblasts. Cancer 38: 2378–2389

    PubMed  CAS  Google Scholar 

  53. Glenner GG, Page DL (1976) Amyloid, amyloidosis, and amyloidogenesis. In: Richter GW, Epstein MA, (eds) International review of experimental pathology. Acad Press, New York, pp 1–92

    Google Scholar 

  54. Shirahama T, Cohen AS (1967) High resolution electron microscopic analysis of the amyloid fibril. J Cell Bioi 33: 679–798

    CAS  Google Scholar 

  55. Allen PW, Enzinger FM (1972) Hemangioma of skeletal muscle. An analysis of 89 cases. Cancer 29: 8–22

    PubMed  CAS  Google Scholar 

  56. Churg A, Ringus I (1978) Ultrastructural observations on the histogenesis of alveolar rhabdomyosarcoma. Cancer 41: 1355–1361

    PubMed  CAS  Google Scholar 

  57. Dehner LP (1975) Pediatric surgical pathology. Mosby, Saint Louis, p 882

    Google Scholar 

  58. Di Sant’Agnese PA, Knowles Ü DM (1980) Extracardiac rhabdomyoma: A clinicopathologic study and review of the literature. Cancer 46: 780–789

    PubMed  Google Scholar 

  59. Enzinger FM, Shiraki M (1969) Alveolar rhabdomyosarcoma. - An analysis of 110 cases. Cancer 24: 18–31

    PubMed  CAS  Google Scholar 

  60. Enzinger FM, Weiss SW (1983) Soft tissue tumors. Mosby, St. Louis Toronto London, p 840

    Google Scholar 

  61. Fox KR, Moussa SM, Mitre RI, Zidar BL, Raves N (1990) Clinical and pathologic features of primary gastric rhabdomyosarcoma. Cancer 66: 772–778

    PubMed  CAS  Google Scholar 

  62. Gad A, Eusebi V (1975) Rhabdomyoma of the vagina. I Pathol Bacteriol 115: 179–181

    CAS  Google Scholar 

  63. Kastendieck H, Böcker W, Hüsselmann H (1976) Zur Ultrastruktur und formalen Pathogenese des embryonalen Rhabdomyosarkoms. Z Krebsforsch 86: 55–68

    CAS  Google Scholar 

  64. Lin n, Lin F (1974) Two entities in angiolipoma. A study of 459 cases of lipoma with review of literature on infiltrating angioliporna. Cancer 34: 720–727

    Google Scholar 

  65. Marquart KH (1978) Intracristale lineare Einschlüsse in Mitochondrien menschlicher Rhabdomyomzellen. Virchows Arch [A] 1 378: 133–141

    Google Scholar 

  66. McClemont IMF, Webb IN (1976) Tumours arising in skeletal muscle in adults. I Pathol 118: 113–120

    CAS  Google Scholar 

  67. Miller RW, Dalager NA (1974) Fatal rhabdomyosarcoma among children in the United States, 1960–1969. Cancer 34: 1897–1900

    PubMed  CAS  Google Scholar 

  68. Reboul-Marty I, Quintana E, Mossere V, Flamant F, Asselain B, Rodary C, Zucker IM (1991) Prognostic factors of alveolar rhabdomyosarcoma in childhood. Cancer 68: 493–498

    PubMed  CAS  Google Scholar 

  69. Schwechheimer K (1990) Pathologie des Nervensystems IV. Spezielle Immunpathologie neurogener Geschwülste. Springer, Berlin Heidelberg New York

    Google Scholar 

  70. Scrivner D, Meyer IS (1980) Multifocal recurrent adult rhabdomyoma. Cancer 46: 790–795

    PubMed  CAS  Google Scholar 

  71. Stout AP, Lattes R (1967) Tumors of the soft tissues, Fasc 1, Atlas of tumor pathology. Armed Forces Institutes of Pathology, WashingtonDC

    Google Scholar 

  72. Waring PM, Newland RC (1992) Prostatic embryonal rhabdomyosarcoma in adults. Cancer 69: 755–762

    PubMed  CAS  Google Scholar 

  73. Agostini B, Noetzel H (1970) Morphological study of muscle fibres and motor end-plates in tatanus. In: Walton IN, Canal N, Scarlato G (eds) Muscle disease (Proceedings of an International Congress, Milan 1969). Int Congr Ser No 199. Excerpta Medica, Amsterdam

    Google Scholar 

  74. Aharonov A, Abransky O, Tarrab-Hazdai R, Fusch S (1975) Humoral antibodies to acetylcholine receptor in patients with myasthenia gravis. Lancet II: 340–342

    Google Scholar 

  75. Arnon SS, Midura TF, Damus K, Thompson B, Wood RM, Chin J (1979) Honey and other environmental risk factors for infant botulism. J Pediatr 94: 282–283

    Google Scholar 

  76. Blank NK, Meerschaert JR, Rieder MJ (1974) Persistent motor neuron discharges of central origin present in the resting state. Neurology (Minneap) 24: 277–281

    CAS  Google Scholar 

  77. Ceccarelli B, Grohovaz F, Hurlbut WP, Iezzi N (1979) Freezefracture studies of frog neuromuscular junctions during intense release of neurotransmitter. I. Effects of black widow spider venom and Ca2+ -free solutions on the structure of the active zone. J Cell Bioi 81: 163–177

    CAS  Google Scholar 

  78. Dieler R, Schröder JM (1990a) Lacunar dilatations of intrafusal and extrafusal terminal cisternae, annulate lamellae, confronting cisternae and tubofilamentous inclusions within the spectrum of muscle and nerve fiber changes in myotonic dystrophy. Pathol Res Pract 186: 371–382

    PubMed  CAS  Google Scholar 

  79. Dieler R, Schröder JM (1990b) Abnormal sensory and motor reinnervation of rat muscle spindles following nerve transaction and suture. Acta Neuropathol 80: 163–171

    PubMed  CAS  Google Scholar 

  80. Dieler R, Schröder JM (1990c) Increase of elastic fibres in muscle spindles of rats following single or repeated denervation with or without reinnervation. Virchows Arch [A] 417: 213–221

    CAS  Google Scholar 

  81. Dieler R, Völker A, Schröder JM (1992) Scanning electron microscopic study of denervated and reinnervated intrafusal muscle fibers in rats. Muscle Nerve 15: 433–441

    PubMed  CAS  Google Scholar 

  82. Duchen LW (1973) The effects of tetanus toxin on the motor endplates of the mouse. An electron microscopic study. J Neurol Sci 19:153–167

    PubMed  CAS  Google Scholar 

  83. Duchen LW (1973) The local effects of tetanus toxin on the electron microscopic structure of skeletal muscle fibres of the mouse. J Neurol Sci 19: 169–177

    PubMed  CAS  Google Scholar 

  84. Duchen LW, Strich SJ (1968) The effects of botulinum toxin on the pattern of innervation of skeletal muscle in the mouse. Quart J Exp Physiol 53: 84–89

    PubMed  CAS  Google Scholar 

  85. Eaton LM, Lambert EH (1957) Electromyography and electric stimulation of nerves in diseases ofthe motor unit. Amer J Physi-ol 163: 1117–1124

    CAS  Google Scholar 

  86. Edmundson RS, Flowerd MW (1979) Intensive care in tetanus. Management, complications and mortality in 100 cases. Br Med J 1401–1404

    Google Scholar 

  87. Engel AG, Lambert EH, Howard FM (1977) Immune complexes (IgG and C3) at the motor end-plate in myasthenia gravis. Ultrastructural and light microscopic localization and electrophysiologic correlations. Mayo Clin Proc 52: 267–280

    PubMed  CAS  Google Scholar 

  88. Engel AG, Lambert EH, Mulder et al. (1981) Recently recognized congenital myasthenic syndromes. Ann NY Acad Sci 377: 614–639

    PubMed  CAS  Google Scholar 

  89. Engel AG, Lindstrom JM, Lambert EH, Lennon VA (1977) Ultrastructural localization of the acetylcholine receptor in myasthenia gravis and in its experimental autoimmune model. Neurology (Minneap) 27: 307–315

    CAS  Google Scholar 

  90. Engel AG, Santa T (1971) Histometric analysis of the ultrastructure of the neuromuscular junction in myasthenia gravis and in the myasthenic syndrome. Ann NY Acad Sci 183: 46–63

    PubMed  CAS  Google Scholar 

  91. Engel AG, Sakakibara H, Sahashi K, Lindstrom JM, Lambert EH, Lennon VA (1979) Passively transferred experimental autoimmune myasthenia gravis. Neurology (Minneap) 29: 179–188

    CAS  Google Scholar 

  92. Engel AG, Tsujihata M, Lambert EH et al. (1976) Experimental autoimmune myasthenia gravis: a sequential and quantitative study of the neuromuscular junction ultrastructure and electrophysiologic correlations. J Neuropathol Exp Neurol 35: 569–587

    PubMed  CAS  Google Scholar 

  93. Fukunaga H, Engel A, Osame M, Lambert EH (1982) Paucity and disorganization of presynaptic membrane active zones in the Lambert-Eaton myasthenic syndrome. Muscle Nerve 5: 686–697

    Google Scholar 

  94. Fukunaga H, Engel AG, Lang B, Newsom-Davis J, Vincent A (1983) Passive transfer of Lambert-Eaton myasthenic syndrome with IgG from man to mouse depletes the presynaptic membrane zones. Proc Natl Acad Sci 80: 7636–7640

    PubMed  CAS  Google Scholar 

  95. Harris JB, Johnson MA, Karlsson E (1975) Pathological responses of rat skeletal muscle to a single subcutaneous injection of a toxin isolated from the venom of the Australian tiger snake, Notechis scutatus scutatus. Clin Exp Pharmacol Physiol 2: 383–404

    CAS  Google Scholar 

  96. Isaacs H (1967) Continuous muscle fiber activity in an Indian male with additional evidence of terminal motor fiber activity. J Neurol Neurosurg Psychiatry 30: 126–131

    PubMed  CAS  Google Scholar 

  97. Jacobs JM, Scaravilli F, Duchen LW, Mertin J (1981) A new neurological rat mutant “mutilated foot”. J Anat 132: 525–543

    PubMed  CAS  Google Scholar 

  98. Jennekens FGI, Hesselmans LFGM, Veldman H, Jansen ENH, Spaans F, Molenaar PC (1992) Deficiency of acetylcholine receptors in a case of end-plate acetylcholinesterase deficiency: a histological investigation. Muscle Nerve 15: 63–72

    PubMed  CAS  Google Scholar 

  99. Laskowski MB, Olson WH, Dettbarn WD (1977) Initial ultrastructural abnormalities at the motor end plate produced by a cholinesterase inhibitor. Exp Neurol 57: 13–33

    PubMed  CAS  Google Scholar 

  100. Love S, Cruz-Hofling MA (1986) Acute swelling of nodes of Ranvier caused by venoms which show inactivation of sodium channels. Acta Neuropathol 70: 1–9

    PubMed  CAS  Google Scholar 

  101. Mertens HG, Ricker K (1968) Ubererregbarkeit der Motoneurone beim “Stiff-man”-Syndrom. Klin Wochenschr 46: 33–42

    PubMed  CAS  Google Scholar 

  102. Mertens HG, Zschocke S (1965) Neuromyotonie. Klin Wochenschr 43: 917–925

    CAS  Google Scholar 

  103. Moersch FP, Woltman HW (1956) Progressive fluctuating muscularrigidity and spasm (“stiff-man” syndrome): Report of a case and some observations in 13 other cases. Proc Mayo Clin 31: 421–427

    CAS  Google Scholar 

  104. Mörl H, Dieterich HA (1980) Nächtliche Wadenkrämpfe – Ursachen und Behandlung. Med Klin 75: 264–267

    PubMed  Google Scholar 

  105. Mora M, Lambert EH, Engel A (1987) Synaptic vesicle abnormality in familial infantile myasthenica. Neurology 37: 206–214

    PubMed  CAS  Google Scholar 

  106. Patrick J, Lindstrom J (1973) Autoimmune response to acetylcholine receptor. Science 180: 871–872

    PubMed  CAS  Google Scholar 

  107. Pearn JH (1977) Neuromuscular paralysis caused by tick envenomation. J Neurol Sci 34: 37–42

    PubMed  CAS  Google Scholar 

  108. Peuckert W (1980) Botulismus. Dtsch Ärztebl, S 330

    Google Scholar 

  109. Robertson WC, Chun RWM, Kornguth SE (1980) Familial infantile myasthenia. Arch Neurol 37: 117–119

    PubMed  CAS  Google Scholar 

  110. Sahashi K, Engel AG, Lambert EH, Howard FM (1980) Ultrastructural localization of the terminal and lytic ninth complement component (C9) at the motor end-plate in myasthenia gravis. J Neuropathol Exp Neurol 39: 160–172

    PubMed  CAS  Google Scholar 

  111. Scaravilli F, Duchen LW (1980) Electron microscopic and quantitative studies of cell necrosis in developing sensory ganglia in normal and sprawling mutant mice. J Neurocytol 9: 373–380

    PubMed  CAS  Google Scholar 

  112. Scaravilli F, Jessell ThM, Dodd J, Chimelli L (1990) Monoclonal antibodies against sensory neuron specific antigens define the extent of neuronal abnormality in the mf mutant rat. Brain 113: 677–689

    PubMed  Google Scholar 

  113. Schröder JM, Heide G, Ramaekers V, Mortier W (1993) Subtotal aplasia of myelinated nerve fibers in the sural nerve. Neuropediatrics 24: 286–291

    PubMed  Google Scholar 

  114. Schröder JM, Kemme PT, Scholz L (1979) The fine structure of denervated and reinnervated muscle spindles: Morphometric studies of intrafusal muscle fibers. Acta Neuropathol 46: 95–106

    PubMed  Google Scholar 

  115. Schroder JM, Völker A, Dieler R (1990) Accumulation of abnormal leptomerfibrils in intrafusal muscle fibers. J Neurol Sci 98 [Suppl]: 338

    Google Scholar 

  116. Schumm F, Stöhr M (1978) Myasthene Syndrome unter Penicillamin- Therapie. Klin Wochenschr 56: 139–144

    PubMed  CAS  Google Scholar 

  117. Simpson JA (1978) Myasthenia gravis: A personal view of pathogenesis and mechanism, part 1. Muscle Nerve 1: 45–56

    PubMed  CAS  Google Scholar 

  118. Simpson JA (1978) Myasthenia gravis: A personal view of pathogenesis and mechanism, part 2. Muscle Nerve 1: 151–156

    PubMed  CAS  Google Scholar 

  119. Zacks SI (1973) The motor endplate. Krieger, Huntington NY

    Google Scholar 

  120. Afifi AK, Rebeiz J, Mire J, Andonian SJ, Der Kaloustian VM (1972) The myopathology of the prune belly syndrome. J Neurol Sci 15:153–165

    PubMed  CAS  Google Scholar 

  121. Beersiek F, Parks AG, Swash M (1979) Pathogenesis of anorectal incontinence. A histometric study of the anal sphincter musculature. J Neurol Sci 42: 111–127

    PubMed  CAS  Google Scholar 

  122. Chou SM, Nonaka I (1978) Werdnig-Hoffmann disease: Proposal of a pathogenetic mechanism. Acta Neuropathol 41: 45–54

    PubMed  CAS  Google Scholar 

  123. Dahl DS, Peters HA (1975) Lipid disturbances associated with spinal muscular atrophy. Clinical, electromyographic, histochemical, and lipid studies. Arch Neurol 32: 195–203

    PubMed  CAS  Google Scholar 

  124. Doyu M, Sobue G, Mukai E, Kachi T, Yasuda T, Mitsuma T, Takahashi A (1992) Severity of X-linked recessive bulbospinal neuronopathy correlates with size of the tandem CAG repeat in androgen receptor gene. Ann Neurol 32: 707–710

    PubMed  CAS  Google Scholar 

  125. Emery AE (1971) Review: The nosology of the spinal muscular atrophies. J Med Genet 8: 481–495

    PubMed  CAS  Google Scholar 

  126. Fidzianska A (1976) Morphological differences between the atrophied small muscle fibres in amyotrophic lateral sclerosis and Werdnig-Hoffmann disease. Acta Neuropathol 34: 321–327

    PubMed  CAS  Google Scholar 

  127. Ghatak NR (1978) Spinal roots in Werdnig-Hoffmann disease. Acta Neuropathol 41: 1–7

    PubMed  CAS  Google Scholar 

  128. Gilliam T, Brzustowicz L, Castilla L et al. (1990) Genetic homogeneity between acute and chronic forms of spinal muscular atrophy. Nature 345: 823–825

    PubMed  CAS  Google Scholar 

  129. Hausmanowa-Petrusewicz I, Zaremba J, Borkowska J (1979) Chronic form of childhood spinal muscular atrophy. Are the problems of its genetics really solved? J Neurol Sci 43: 313–327

    Google Scholar 

  130. Jennekens FGI, Meijer AEFH, Bethlem J, Van Wijngaarden GK (1974) Fibre hybrids in type groups. An investigation of human muscle biopsies. J Neurol Sci 23: 337–352

    PubMed  CAS  Google Scholar 

  131. Mann DMA, Yates PO (1974) Motor neurone disease: the nature of the pathogenic mechanism. J Neurol Neurosurg Psychiatry 37: 1036–1046

    Google Scholar 

  132. Matsuura T, Demura T, Aimoto Y, Mizuno T, Moriwaka F, Tashiro K (1992) Androgen receptor abnormality in X-linked spinal and bulbar muscular atrophy. Neurology 42: 1724–1726

    PubMed  CAS  Google Scholar 

  133. Rorke LB (1992) Anatomical features of the developing brain implicated in pathogenesis of hypoxic-ischemic injury. Brain Pathol 2: 211–221

    PubMed  CAS  Google Scholar 

  134. Spatz H (1938) Die “systematischen Atrophien”. Eine wohlgekennzeichnete Gruppe der Erbkrankheiten des Nervensystems. Arch Psychiatr 108: 1–18

    Google Scholar 

  135. Towfighi J, Marks K, Palmer E, Vannucci R (1979) Mobius syndrome. Neuropathologic observations. Acta Neuropathol 48: 11–17

    PubMed  CAS  Google Scholar 

  136. Black JT, Bhatt GP, Dejesus PV, Schotland DL, Rowland LP (1974) Diagnostic accuracy of clinical data, quantitative electromyography and histochemistry in neuromuscular disease. A study of 105 cases. J Neurol Sci 21: 59–70

    PubMed  CAS  Google Scholar 

  137. Bullen AJ, Eccles JC, Eccles RM (1960) Interactions between motoneurones and muscles in respect of the characteristic speeds of their responses. J Physiol (Lond) 150: 417–439

    Google Scholar 

  138. Bundschu HD, Suchenwirth R (1973) Primäre und sekundare Myopathien aus ezymhistologischer Sicht. Fortschr Neurol Psychiatr 41: 419–449

    CAS  Google Scholar 

  139. Cohen MW, Weldon PR (1980) Localization of acetylcholine receptors and synaptic ultrastructure at nerve-muscle contacts in culture: Dependence on nerve type. J Cell Bioi 86: 388–401

    CAS  Google Scholar 

  140. Edstrom L, Grimby L (1986) Effect of exercise on the motor unit. Muscle Nerve 9: 104–126

    PubMed  CAS  Google Scholar 

  141. Edstrom L, Kugelberg E (1968) Histochemical composition, distribution of fibres and fatiguability of single motor units. Anterior tibial muscle of the rat. J Neurol Neurosurg Psychiatry 31: 424–433

    PubMed  CAS  Google Scholar 

  142. Engel WK (1961) Muscle target fibers, a newly recognized sign of denervation. Nature 191: 389

    PubMed  CAS  Google Scholar 

  143. Gollnick PD, Armstrong RB, Saltin B, Sauber IV, Sembrowich WL, Shepherd RE (1973) Effect of training on enzyme activity and fiber composition of human skeletal muscle. J Appl Physiol 34:107–111

    PubMed  CAS  Google Scholar 

  144. Gutmann E, Zelená J (1962) Morphological changes in the denervated muscle. In: Gutman E (ed) The denervated muscle. Czechoslovak Acad Sci, Prague. pp57–102

    Google Scholar 

  145. Karpati G, Engel WK (1968) “Type grouping” in skeletal muscles after experimental reinnervation. Neurology (Minneap) 18: 447–455

    CAS  Google Scholar 

  146. Karpati G, Engel WK (1968) Correlative histochemical study of skeletal muscle after suprasegmental denervation, peripheral nerve section and skeletal fixation. Neurology (Minneap) 18: 681–692

    CAS  Google Scholar 

  147. Lomo T, Westgaard RH, Engebretsen L (1980) Different stimulation patterns affect contractile properties of denervated rat soleus muscles. In: Pette D (ed) Pasticity of muscle. DeGruyter, Berlin New York, pp 297–309

    Google Scholar 

  148. McGeachie J, Allbrook D (1978) Cell proliferation in skeletal muscle following denervation or tenotomy. Cell Tiss Res 193: 259–267

    CAS  Google Scholar 

  149. Meltzer HY, Rastogi S, Ellison J (1976) Quantitative histochemical evaluation of normal human skeletal muscle. Neurology (Minneap) 26: 849–852

    CAS  Google Scholar 

  150. Mittelbach F (1966) Die Begleitmyopathie bei neurogenen Atrophien. Springer, Berlin Heidelberg New York (aus dem Gesamtgebiet der Neurologie und Psychiatrie, 113. Heft)

    Google Scholar 

  151. Nix W, Reichmann H, Schröder JM (1985) Influence of direct low frequency stimulation on contractile properties of denervated fast twitch rabbit muscle. Pflügers Arch 405: 141–147

    PubMed  CAS  Google Scholar 

  152. Pellegrino C, Franzini C (1963) An electron microscope study of denervation atrophy in red and white skeletal muscle fibers. J Cell Bioi 17: 327–349

    CAS  Google Scholar 

  153. Pihko H, Lehtinen I, Tikkanen H, Harkonen M, Rapola J, Lamminen A, Sahlman A, Somer H (1993) Progressive unilateral hypertrophic myopathy: A case study. Muscle Nerve 16: 63–68

    PubMed  CAS  Google Scholar 

  154. Rubinstein N, Mabuchi K, Pepe F, Salmons S, Gergely J, Sréter F (1978) Use of type-specific antimyosins to demonstrate the transformation of individual fibers in chronically stimulated rabbit fast muscles. J Cell Bioi 79: 252–261

    CAS  Google Scholar 

  155. Salmons S, Vrbová G (1969) The influence of activity on some contractile characteristics of mammalian fast and slow muscle. J Physiol (Lond) 210: 535–549

    Google Scholar 

  156. Schotland DL (1969) An electron microscopic study of target fibers, target-like fibers and related abnormalities in human muscle. J Neuropathol Exp Neurol 28: 214–228

    CAS  Google Scholar 

  157. Staudte HW, Brussatis F (1977) Selective changes in size and distribution of fibre types in vastus muscle from cases of different knee joint affections. Z Rheumatol 36: 143–160

    PubMed  CAS  Google Scholar 

  158. Stonnington HH, Engel AG (1973) Normal and denervated muscle. A morphometric study of fine structure. Neurology (Minneap) 23: 714–724

    CAS  Google Scholar 

  159. Sunderland S, Ray U (1950) Denervation changes in mammalian striated muscle. J Neurol Neurosurg Psychiatry 13: 159–177

    PubMed  CAS  Google Scholar 

  160. Tosi C, Jerusalem F (1976) Selektive Muskelfasertypenanomalien bei neuromuskularen Erkrankungen. Eine Analyse von 124 konsekutiven, histochemisch bearbeiteten Biopsien. JNeuro 1214: 13–24

    Google Scholar 

  161. Ashby P, Verrier M (1976) Neurophysiologic changes in hemiplegia. Neurology (Minneap) 26: 1145–1151

    CAS  Google Scholar 

  162. Brooke M (1977) A clinicians view of neuromuscular diseases. Williams & Wilkins, Baltimore. p240

    Google Scholar 

  163. Edström L (1970) Selective changes in the sizes ofred and white muscle fibres in upper motor lesions and parkinsonism. J Neurol Sci 11: 537–550

    PubMed  Google Scholar 

  164. Emery AEH, Holloway S (1982) Familial motor neuron diseases. In: Rowland LP (ed) Human motor neuron diseases. Raven, New York. pp 139–145

    Google Scholar 

  165. Fidzianska A (1976) Morphological differences between the atrophied small muscle fibres in amyotrophic lateral sclerosis and Werdnig-Hoffmann disease. Acta Neuropathol 34: 321–327

    PubMed  CAS  Google Scholar 

  166. Karpati G, Engel WK (1962) Correlative histochemical study of skeletal muscle after suprasegmental de nervation. Peripheral nerve section and skeletal fixation. Neurology (Min neap) 18: 681–692

    Google Scholar 

  167. Kurtzke JF (1982) Epidemiology of amyotrophic lateral sclerosis. In: Rowland LP (ed) Human motor neuron diseases, Raven, New York. pp281–302

    Google Scholar 

  168. Lindenberg R, Rubinstein LH, Hermann MM, Haydon GB (1968) A light and electron microscopy study of an unusal widespread nuclear inclusion body disease. A possible residuum of an old herpesvirus infection. Acta Neuropathol 10: 54–73

    PubMed  CAS  Google Scholar 

  169. McComas AJ (1977) Neuromuscular function and disorders. Butterworths, London Boston

    Google Scholar 

  170. Meltzer HY, McBride E, Poppei RW (1973) Rod (nemaline) bodies in the skeletal muscle of an acute schizophrenic patient. Neurology (Minneap) 23: 769–780

    CAS  Google Scholar 

  171. Patten BM, Zito G, Harati Y (1979) Histologic findings in motor neuron disease. Relation to clinically determined activity, duration. and severity of disease. Arch Neurol 36: 560–564

    PubMed  CAS  Google Scholar 

  172. Pongratz D (1976) Differentialdiagnose der Erkrankungen der Skelettmuskulatur an hand von Muskelbiopsien. Enzymhistochemische und histometrische Untersuchungen zur besonderen Vulnerabilitat der Typ-II-Faser. In: Scheid W, Wieck HH, Peters UH (Hrsg) Sammlung psychiatrischer und neurologischer Einzeldarstellungen. Thieme. Stuttgart

    Google Scholar 

  173. Rowland LP (1982) Human motor neuron diseases. Raven, New York

    Google Scholar 

  174. Schröder JM, Krämer KG, Hopf HC (1985) Granular inclusion body disease: fine structure of tibial muscle and sural nerve. Muscle Nerve 8: 52–59

    PubMed  Google Scholar 

  175. Swash M, Schwartz MS (1992) What do we really know about amyotrophic lateral sclerosis? Review article. J Neurol Sci 113: 4–16

    PubMed  CAS  Google Scholar 

  176. Yanagihara R (1982) Heavy metals and essential minerals in motor neuron disease. In: Rowland LP (ed) Human motor neuron diseases. Raven. New York. pp233–247

    Google Scholar 

Literatur

  1. Barker D (1974) The morphology of muscle receptors. In: Hunt CC, (ed) Handbook of sensory physiology, vol III/2. Springer, Berlin Heidelberg New York, pp 1–190

    Google Scholar 

  2. Boyd IA, Davey MR (1968) Composition of peripheral nerves. Livingstone, Edinburgh

    Google Scholar 

  3. Brooke MH, Kaiser KK (1974) The use and abuse of muscle histochemistry. Ann NY Acad Sci 228: 121–144

    PubMed  CAS  Google Scholar 

  4. Clara M (1949) Entwicklungsgeschichte des Menschen, 4. Aufl. Quelle & Meyer, Heidelberg

    Google Scholar 

  5. Edwards RHT, Jones DA, Maunder CA, Batra GH (1975) Needle biopsy for muscle chemistry. Lancet 1: 736–740

    PubMed  CAS  Google Scholar 

  6. Engel AG (1970) Locating motor end plates for electron microscopy. Mayo Clin Proc 45: 450–454

    PubMed  CAS  Google Scholar 

  7. Farkas-Bargeton E, Diebler MG, Arsénio-Nunes ML, Wehrlé R, Rosenberg B (1977) Etude de la maturation histocémique, quantitative et ultrastructurale du muscle foetal humain. J Neurol Sci 31: 245–259

    PubMed  CAS  Google Scholar 

  8. Hasselbach W (1971) Muskel. In: Physiologie, 4. Heft. Urban & Schwarzenberg, Munchen

    Google Scholar 

  9. Johnson MA, Polgar J, Weightmann D, Appleton D (1973) Data on the distribution of fibre types in thirty-six human muscles. An autopsy study. J Neurol Sci 18: 111–129

    PubMed  CAS  Google Scholar 

  10. Polgar J, Johnson MA, Weightmann D, Appleton D (1973) Data on fibre size in thirty-six human muscles. An autopsy study. J Neurol Sci 19:307–318

    PubMed  CAS  Google Scholar 

  11. Porro RS, Webster H de F, Tobin W (1969) Needle biopsy of skeletal muscle: a phase and electron microscopic evaluation of its usefulness in the study of muscle disease. J Neuropathol Exp Neurol 28:229–242

    PubMed  CAS  Google Scholar 

  12. Ringqvist M (1974) Size and distribution of histochemical fibre types in masseter muscle of adults with different states of occlusion. J Neurol Sci 22: 429–438

    PubMed  CAS  Google Scholar 

  13. Walton JN, Rowland LP, McLeod JG (1994) Classification of neuromuscular diseases. J Neurol Sci 125 (Suppl) 109–130

    Google Scholar 

  14. Zacks SI (1973) The motor endplate. Krieger, Huntington/NY

    Google Scholar 

Literatur

  1. Schröder JM, Hopf HC, Wagner G, Amelung F, (Hrsg) (1989) Neuromuskulare Krankheiten. Springer, Berlin Heidelberg New York Tokyo

    Google Scholar 

Literatur

  1. Becker PE (1972) Neues zur Genetik und Klassifikation der Muskeldystrophien. Humangenetik 17: 1–22

    PubMed  CAS  Google Scholar 

  2. Becker PE, Kiener F (1955) Eine neue X-chromosomale Muskeldystrophie. Arch Psychiatr Z Neurol 193: 427–448

    CAS  Google Scholar 

  3. Biemond A (1955) Myopathia distalis juvenilis hereditaria. Acta Psychiatr Scand 30: 25–38

    CAS  Google Scholar 

  4. Bodensteiner LB, Engel AG (1978) Intracellular calcium accumulation in Duchenne dystrophy and other myopathies: A study of 567000 muscle fibers in 114 biopsies. Neurology (Minneap) 28: 439–446

    CAS  Google Scholar 

  5. Borg J, Griby L, Hannerz J (1979) Motor neuron firing range, axonal conduction velocity, and muscle fiber histochemistry in neuromuscular diseases. Muscle Nerve 2: 423–430

    PubMed  CAS  Google Scholar 

  6. Boxler K, lerusalem F (1978) Hyperreactive (hyaline, opaque, dark) muscle fibers in Duchenne dystrophy. A biopsy study of 16 dystrophy and 205 other neuromuscular disease cases and controis. J Neurol 219: 63–72

    PubMed  CAS  Google Scholar 

  7. Clemens PR, Ward PA, Caskey CT, Bulman DE, Fenwick RG (1992) Premature chain termination mutation causing Duchenne muscular dystrophy. Neurology 42: 1775–1782

    PubMed  CAS  Google Scholar 

  8. Cruse JP, Edwards DAW, Smith IF, Wyllie JH (1979) The pathology of a cricopharyngeal dysphagia. Histopathology 3: 223–232

    PubMed  CAS  Google Scholar 

  9. Cullen MJ, Fulthorpe JJ (1975) Stages in fibre breakdown in Duchenne muscular dystrophy. An electron-microscopic study. J Neurol Sci 24:179–200

    PubMed  CAS  Google Scholar 

  10. Dubowitz V, Crome L (1969) The central nervous system in Duchenne muscular dystrophy. Brain 92: 805–808

    PubMed  CAS  Google Scholar 

  11. Edström L (1975) Histochemical and histopathological changes in skeletal muscle in late-onset hereditary distal myopathy (Welander). J Neurol Sci 26: 147–157

    Google Scholar 

  12. Emery AEH (1991) Population frequencies of inherited neuromuscular diseases - a world survey. Neurom Dis 1: 19–29

    CAS  Google Scholar 

  13. Fanin M, Danieli G, Vitiello L, Senter L, Angelini C (1992) Prevalence of dystrophin-positive fibers in 85 Duchenne muscular dystrophy patients. Neurom Dis 2: 41–45

    CAS  Google Scholar 

  14. Frankel KA, Rosser RJ (1976) The pathology of the heart in progressive muscular dystrophy: epimyocardial fibrosis. Hum Pathol 7:375–386

    PubMed  CAS  Google Scholar 

  15. Gallanti A, Prelle A, Moggio M, Ciscato P, Checcarelli N, Sciacco M, Comini A, Scarlato G (1992) Desmin and vimentin as markers of regeneration in muscle diseases. Acta Neuropathol 85: 88–92

    PubMed  CAS  Google Scholar 

  16. Goebel HH, Prange H, Gullotta F, Kiefer H, Jones MH (1979) Becker’s X-linked muscular dystrophy. Histological, enzymehistochemical, and ultrastructural studies of two cases, originally reported by Becker. Acta Neuropathol 49: 35–41

    Google Scholar 

  17. Gold R, Kress W, Meurers B, Meng G, Reichmann H, Müller CR (1992) Brief communication: Becker muscular dystrophy: detection of unusual disease courses by combined approach to dystrophin analysis. Muscle Nerve 15: 214–218

    PubMed  CAS  Google Scholar 

  18. Hammersen F, Gidlöf L, Larsson J, Lewis DH (1980) The occurrence of paracrystalline mitochondrial inclusions in normal human skeletal muscle. Acta Neuropathol 49: 35–41

    PubMed  CAS  Google Scholar 

  19. Hoffman EP, Brown RH, Kunkel LM (1987) Dystrophin: the protein product of the Duchenne muscular dystrophy locus. Cell 51: 919–928

    PubMed  CAS  Google Scholar 

  20. Ioannou P, Christopoulos G, Panayides K, Kleanthous M, Middleton L (1992) Detection of Duchenne and Becker muscular dystrophy carriers by quantitative multiplex polymerase chain reaction analysis. Neurology 42: 1783–1790

    PubMed  CAS  Google Scholar 

  21. Lennekens GFI, Ten Tate LP, De Visser M, Wintzen AR (1991) Diagnostic criteria for Duchenne and Becker muscular dystrophy and myotonic dystrophy. Neurom Dis 1: 389–391

    Google Scholar 

  22. Lerusalem F, Engel AG, Gomez MR (1974) Duchenne dystrophy. I. Morphometric study of the muscle microvasculature. Brain 97: 115–122

    Google Scholar 

  23. Lerusalem F, Engel AG, Gomez MR (1974) Duchenne dystrophy. II. Morphometric study of motor end-plate fine structure. Brain 97: 123–130

    Google Scholar 

  24. Johnson MA, Kohen Kucukyalcin D (1978) Patterns of abnormal histochemical fibre type differentiation in human muscle biopsies. J Neurol Sci 159–178

    Google Scholar 

  25. Koenig M, Monaco AP, Kunkel LM (1988) The complete sequence of dystrophin predicts a rod-shaped cytoskeletal protein. Cell 53:219–228

    PubMed  CAS  Google Scholar 

  26. Kuhn E, Schröder JM (1981) Autosomal recessively inherited distal myopathy: A new type of distal myopathy. J Neurol 226: 181–185

    PubMed  CAS  Google Scholar 

  27. Leyten QH, Ter Laak HL, Gabreëls FJM, Renier WO, Sengers RCA (1993) Congenital muscular dystrophy: a study on the variability of morphological changes and dystrophin distribution in muscle biopsies. Acta Neuropathol 86: 386–392

    PubMed  CAS  Google Scholar 

  28. Lindberg Ch, Borg K, Edström L, Hedström A, Oldfors A (1991). Inclusion body myositis and Welander distal myopathy: A clinical, neurophysiological and morphological comparison. J Neuro Sci 103: 76–81

    CAS  Google Scholar 

  29. Mastaglia FL, Kakulas BA (1969) Regeneration in Duchenne muscular dystrophy: a histochemical study. Brain 92: 809–818

    PubMed  CAS  Google Scholar 

  30. McKusick VA (ed) (1992) Mendelian Inheritance in Man. Catalogs of autosomal dominant, autosomal recessive and X-linked phenotypes, 10th edn, vol 1 and 2. John Hopkins Univ Press, Baltimore London

    Google Scholar 

  31. Miller G (1992) Diagnostic criteria for Duchenne and Becker muscular dystrophy. Neurom Dis 2: 225

    CAS  Google Scholar 

  32. Minetti C, Tanji K, Bonilla E (1992) Immunologic study ofvinculin in Duchenne muscular dystrophy. Neurology 42: 1751–1754

    PubMed  CAS  Google Scholar 

  33. Miyoshi K, Kawai H, Iwasa M, Kusaka K, Nishino H (1986) Autosomal recessive distal muscular dystrophy as a new type of progressive muscular dystrophy. Brain 109: 31–54

    PubMed  Google Scholar 

  34. Mizusawa H, Kurisaki H, Takatsu M, Inou K, Mannen T, Toyokura Y, Nakanishi T (1987) Rimmed vacuolar distal myopathy. A clinical, electrophysiological, histopathological and computed tomographic study of 7 cases. J Neurol 234: 129–136

    PubMed  CAS  Google Scholar 

  35. Mokri B, Engel AG (1975) Duchenne Dystrophy: Electron microscopic findings pointing to a basic or early abnormality in the plasma membrane of the muscle fiber. Neurology (Minneap) 25: 1111–1120

    CAS  Google Scholar 

  36. Moser H, Wiesmann U, Richterich R, Rossi E (1964) Progressive Muskeldystrophie. VI. Häufigkeit, Klinik und Genetik der Duchenne- Form. Schweiz Med Wochenschr 94: 1610

    PubMed  CAS  Google Scholar 

  37. Nicholson LVB, 10hnson MA, Gardner-Medwin D, Bhattacharya S, Harris LB (1990) Heterogenety of dystrophin expression in patients with Duchenne and Becker muscular dystrophy. Acta Neuropathol 80: 239–250

    PubMed  CAS  Google Scholar 

  38. Pongratz D (1976) Differentialdiagnose der Erkrankungen der Skelettmuskulatur anhand von Muskelbiopsien. Enzymhistochemische und histochemische Untersuchungen zur besonderen Vulnerabilität der Typ II-Faser. In: Scheid W, Wieck HH, Peters UH, (Hrsg) Sammlung psychiatrischer und neurologischer Einzeldarstellungen. Thieme, Stuttgart, S 107

    Google Scholar 

  39. Quinlivan RM, Dubowitz V (1992) Cardiac transplantation in Becker muscular dystrophy. Neurom Dis 2: 165–167

    CAS  Google Scholar 

  40. Ringel SP, Carrol JE, Schold SC (1977) The spectrum of mild Xlinked recessive muscular dystrophy. Arch Neurol 34: 408–416

    PubMed  CAS  Google Scholar 

  41. Schmalbruch H (1975) Segmental fibre breakdown and defects of the plasmalemma in diseased human muscles. Acta Neuropathol 33:129–141

    PubMed  CAS  Google Scholar 

  42. Schröder JM, Krabbe B, Weis J (1995) Oculopharyngeal muscular dystrophy: Clinical and morphological follow-up-study reveals mitochondrial alterations and unique nuclear inclusions in a severe autosomal recessive type. Neuropath Appl Neuro Biol (in press)

    Google Scholar 

  43. Sunohara N, Nonaka I, Kamei N, Satoyoshi E (1989) Distal myopathy with rimmed vacuole formation. A follow-up study. Brain 112: 65–83

    Google Scholar 

  44. Swash M, Schwartz MS, Thompson A, Cox E, Gray A (1988) Distal myopathy with focal granular degenerative change in vacuolated type 2 fibers. Clin Neuropathol 7: 249–253

    PubMed  CAS  Google Scholar 

  45. Thornell LE, Edström L, Billeter R, Butler-Browne GS, Kjörell U, Whalen RG (1984) Muscle fibre type composition in distal myopathy (Welander). J Neurol Sci 65: 269–292

    PubMed  CAS  Google Scholar 

  46. Tomé FMS, Fardeau M (1980) Nuclear inclusions in oculopharyngeal dystrophy. Acta Neuropathol 49: 85–87

    PubMed  Google Scholar 

  47. Vassilopoulos D, Lumb EM, Emery AE (1976) Muscle nuclear size in neuromuscular disease. J Neurol Neurosurg Psychiatry 39: 159–162

    PubMed  CAS  Google Scholar 

  48. Victor M, Hayes R, Adams RD (1962) Oculopharyngeal muscular dystrophy. New Engl J Med 267: 1267–1272

    PubMed  CAS  Google Scholar 

  49. Wakayama Y, Schotland DL, Bonilla E, Orecchio E (1979) Quantitative ultrastructural study of muscle satellite cells in Duchenne dystrophy. Neurology (Minneap) 29: 401–407.

    CAS  Google Scholar 

  50. Welander L (1951) Myopathia distal is tarda heredltana. 249 examined cases in 72 pedigrees. Acta Med Scand 141 [Suppl]: 265

    Google Scholar 

  51. Zatz M, Matsumura K, Vainzof M, Passos-Bueno MR, Pavanello RCM, Marie SK, Campbell KP (1994) Assessment of the 50-k Da dystrophin-associated glycoprotein in Brazilian patients with severe childhood autosomal recessive muscular dystrophy. J N euro Sci 123: 122–128

    CAS  Google Scholar 

Literatur

  1. Brooke MH (1973) A neuromuscular disease characterized by fibre types disproportion. In: Kakulas BA, (ed) Proceedings of the second international congress on muscle disease. Perth, Australia, November 1971. Intern Congr Ser No 282, Excerpta Medica, Amsterdam

    Google Scholar 

  2. Brooke MH (1977) A clinican’s view of neuromuscular diseases. Williams & Wilkins, Baltimore

    Google Scholar 

  3. Brooke MH, Neville HE (1972) Reducing body myopathy. Neurology (Minneap) 22: 829–840

    CAS  Google Scholar 

  4. Brownell AKW, Gilbert JJ, Garcia B, Wenkebach GF, Lam AKS (1978) Adult onset nemaline myopathy. Neurology (Minneap) 28: 1306–1309

    CAS  Google Scholar 

  5. Cancilla PA, Kalyanaraman K, Verity MA, Munsat T, Pearson CM (1971) Familial myopathy with probable lysis of myofibrils in type I fibers. Neurology (Minneap) 21: 579–585

    CAS  Google Scholar 

  6. Carpenter S, Karpati G, Robitaille Y, Melmed C (1979) Cylindrical spirals in human skeletal muscle. Muscle Nerve 2: 282–287

    PubMed  CAS  Google Scholar 

  7. Carpenter S, Karpati G, Holland P (1992) A chronic myopathy with coated vesicles and tubular masses. Neurom Dis 2: 209–216

    CAS  Google Scholar 

  8. Conen PE, Murphy EG, Donohue WL (1963) Light and electron microscopic studies of “myogranules” in a child with hypotonia and muscle weakness. Can Med Assoc J 89: 983

    PubMed  CAS  Google Scholar 

  9. Denborough MA, Dennet X, Anderson RMCD (1973) Centralcore disease and malignant hyperpyrexia. Br Med J 1: 272

    PubMed  CAS  Google Scholar 

  10. Engel AG, Angelini C, Gomez MR (1972) Fingerprint body myopathy. A newly recognized congenital muscle disease. Proc Mayo Clin 47: 377–388

    PubMed  CAS  Google Scholar 

  11. Engel AG, Gomez MR (1967) Nemaline (Z-disc) myopathy, observations on the origin, structure, and solubility properties of the nemaline structure. J Neuropathol Exp Neurol 26: 601–609

    PubMed  CAS  Google Scholar 

  12. Engel AG, Gomez MR, Groovers RV (1971) Multicore disease. A recently recognized congenital myopathy associated with multifocal degeneration of muscle fibers. Mayo Clin Proc 46: 666–681

    PubMed  CAS  Google Scholar 

  13. Engel WK, Gold GN, Karpati G (1968) Typ I fiber hypotrophy and central nuclei. A rare congenital muscle abnormality with a possible experimental model. Arch Neurol 18: 435–444

    PubMed  CAS  Google Scholar 

  14. Fardeau M, Godet-Guillain J, Tomé FMS, Collin H, Gaudeau S, Boffety C, Vernant P (1978) Une nouvelle affection musculaere familiale, définie par l’accumulation intra-sarco-plasmique d’un matérial granulo-filamentaire dense en microscopie électronique. Rev Neurol (Paris) 131: 411–425

    Google Scholar 

  15. Farkas-Bargeton E, Aicardi J, Arsenio-Nunes ML, Wehrle R (1978) Delay in the maturation of muscle fibers in infants with congenital hypotonia. J Neurol Sci 39: 17–29

    PubMed  CAS  Google Scholar 

  16. Fidzianska A, Bardurska B, Ryniewicz B, Dembek I (1981) “Cap disease”: New congenital myopathy. Neurology (NY) 31: 1113–1120

    CAS  Google Scholar 

  17. Fukuhara N, Kumamoto T, Hirahara H, Tsubaki T (1981) A new myopathy with tubulomembranous inclusions. J Neurol Sci 50: 95–107

    PubMed  CAS  Google Scholar 

  18. Gibbels E, Kellermann K, Schädlich H-J, Adam R, Haupt WF (1992) Follow-up studies in a case of unusual congenital myopathy, suggestive of nemaline type. Acta Neuropathol 83: 371–378

    PubMed  CAS  Google Scholar 

  19. Goebel HH, Muller J, Gillen HW, Merrit AD (1978) Autosomal dominant “spheroid body myopathy”. Muscle Nerve 1: 14–26

    PubMed  CAS  Google Scholar 

  20. Isaacs H, Heffron JJA, Badenhorst M (1975) Central core diseases. A correlated genetic, histochemical, ultramicroscopic, and biochemical study. J Neurol Neurosurg Psychiatry 38: 1177–1186

    PubMed  CAS  Google Scholar 

  21. Jadro-Šantel D, Grcevic N, Dogan S, Franjic F, Benc H (1980) Centronuclear myopathy with type 1 fiber hyotrophy and “fingerprint” inclusions associated with Marfan’s syndrome. J Neurol Sci 45: 43–56

    Google Scholar 

  22. Jay V, Christodoulou J, Mercer-Connolly AM, McInnes RR (1992) “Reducing body” -like inclusions in skeletal muscle in childhood- onset acid maltase deficiency. Acta Neuropathol 85: 111–115

    PubMed  CAS  Google Scholar 

  23. Jerusalem F, Engel AG, Gomez MR (1973) Sarcotubular myopathy. A newly recognized, benign, congenital, familial muscle disease. Neurology (Minneap) 23: 897–906

    CAS  Google Scholar 

  24. Jerusalem F, Ludin H, Bischoff A, Hartmann G (1979) Cytoplasmic body neuromyopathy presenting as respiratory failure and weight loss. J Neurol Sci 41: 1–9

    PubMed  CAS  Google Scholar 

  25. Kinoshita M, Satoyoshi E, Suzuki Y (1975) Atypical myopathy with myofibrillar aggregates. Arch Neurol 32: 417–420

    PubMed  CAS  Google Scholar 

  26. Lake BD, Wilson J (1975) Zebra body myopathy. Clinical histochemical and ultrastructural studies. J Neurol Sci 24: 437–446

    PubMed  CAS  Google Scholar 

  27. Misra AY, Menon NK, Mishra SK (1992) Abnormal distribution of desmin and vimentin in myofibers in adult onset myotubular myopathy. Muscle Nerve 15: 1246–1252

    PubMed  CAS  Google Scholar 

  28. Morgan-Hughes JA, Brett EM, Lake BD, Tomé FMS (1973) Central core disease or not? Brain 96: 527–536

    PubMed  CAS  Google Scholar 

  29. Nakashima N, Tamura Z, Okamoto S, Goto H (1970) Inclusion bodies in human neuromuscular disorder. Arch Neurol 22: 270–278

    PubMed  CAS  Google Scholar 

  30. Osborn M, Goebel HH (1983) The cytoplasmic bodies in a congenital myopathy can be stained with antibodies to desmin, the muscle-specific intermediate filament protein. Acta Neuropathol 62:149–152

    PubMed  CAS  Google Scholar 

  31. Pongratz D, Weindl A, Reichl W, Koppenwallner Ch, Heuser M, Hübner G (1976) Kongenitale zentronukleäre Myopathie. Zwei morphologische Varianten in einer Familie. Klin Wochenschr 54: 423–430

    PubMed  CAS  Google Scholar 

  32. Prelle A, Moggio M, Comi GP, Gallanti A, Checcarelli N, Bresolin N, Ciscato P, Fortunato F, Scarlato G (1992) Congenital myopathy associated with abnormal accumulation of desmin and dystrophin. Neurom Dis 2: 169–175

    CAS  Google Scholar 

  33. Ringel SP, Neville HE, Duster MC, Carroll JE (1978) A new congenital neuromuscular disease with trilaminar muscle fibers. Neurology (Minneap) 28: 282–289

    CAS  Google Scholar 

  34. Robertson EC, Kawamura Y, Dyck PJ (1978) Morphometric study of motoneurons in congenital nemaline myopathy and Werdnig- Hoffman diesease. Neurology (Minneap) 28: 1057–1061

    Google Scholar 

  35. Saghal V, Subramani V, Hughes R, Shah A, Singh H (1979) On the pathogenesis of mitochondrial myopathies. An experimental study. Acta Neuropathol 46: 177–183

    Google Scholar 

  36. Schröder JM (1995) Congenital fiber type disproportion. In: Lane RIM, (ed): Handbook of Muscle Diseases. Marcel Dekker: New York (in press)

    Google Scholar 

  37. Schröder JM, Sommer C, Schmidt B (1990) Desmin and actin associated with cytoplasmic bodies in skeletal muscle fibers: immunocytochemical and fine structural studies, with a note on unusual 18- to 20-nm filaments. Acta Neuropathol 80: 406–414

    Google Scholar 

  38. Sewry CA, Voit T, Dubowitz V (1988) Myopathy with unique ultrastructural feature in Marinesco-Sjögren syndrome. Ann Neurol 24: 576–580

    PubMed  CAS  Google Scholar 

  39. Sher JH, Rimalowski AB, Athanassiades TJ, Aronson SM (1967) Familial centronuclear myopathy: a clinical and pathological study. Neurology (Minneap) 17: 727–742

    CAS  Google Scholar 

  40. Shy GM, Engel KW, Sommers JE, Wanko T (1963) Nemaline myopathy, a new congenital myopathy. Brain 68: 793–810

    Google Scholar 

  41. Shy GM, Gonatas NK, Perez M (1966) Two childhood myopathies with abnormal mitochondria. I. Megaconial myopathy. II. Pleoconial myopathy. Brain 89: 133–158

    PubMed  CAS  Google Scholar 

  42. Shy GM, Magee KR (1956) A new congenital non-progressive myopathy. Brain 79: 610–621

    PubMed  CAS  Google Scholar 

  43. Spiro AJ, Shy GM, Gonatas NK (1966) Myotubularmyopathy. Persistence offetal muscle in an adolescent boy. Arch Neurol 14: 1–14

    PubMed  CAS  Google Scholar 

  44. Taratuto AL, Sfaello ZM, Rezzonico C, Morales RC (1978) Multicore disease. Report of a case with lack of fibre type differentiation. Neuropädiatrie 9: 285–297

    PubMed  CAS  Google Scholar 

  45. Yarom R, Shapira Y (1977) Myosin degeneration in a congenital myopathy. Arch Neurol 34: 114–115

    PubMed  CAS  Google Scholar 

  46. Zimmer C, Gosztonyi G, Cervos-Navarro J, Moers A, Schröder JM (1992) Neuropathy with lysosomal changes in Marinesco-Sjögren syndrome: Fine structural findings in skeletal muscle and conjunctiva. Neuropediatrics 23: 329–335

    PubMed  CAS  Google Scholar 

  47. Zimmermann P, Weber U (1979) Familial centronuclear myopathy: a haploid DNA disease? Acta Neuropathol 46: 209–214

    PubMed  CAS  Google Scholar 

Literatur

  1. Becker PE (1970) Paramyotonia congenita (Eulenburg). In: Becker PE, Lenz W. Vogel F. Wendt GG, (Hrsg) Fortschritte der allgemeinen und klinischen Humangenetik, Bd III. Thieme. Stuttgart

    Google Scholar 

  2. Becker PE (1977) Myotonia congenita and syndromes associated with myotonia. Clinical-genetic studies of the nondystrophic myotonias. In: Becker PE, Lenz W, Vogel F, Wendt GG, (eds) Topics in human genetics. Thieme, Stuttgart

    Google Scholar 

  3. Bergmann RA, Afifi AK, Dunkle LM, Johns RJ (1970) Muscle pathology in hypokaliemic periodic paralysis with hyperthyroidism. Johns Hopk Mcd J 126: 100–118

    Google Scholar 

  4. Borenstein S, Noel P, Jacquy J, Flament-Durand J (1977) Myotonic dystrophy with nerve hypertrophy. J Neurol Sci 34: 87–99

    PubMed  CAS  Google Scholar 

  5. Brook JD, McCurrach ME, Harley HG (1992) Molecular basis of myotonic dystrophy: expansion of a trinucleotide (CTG) repeat at the 3’ end of a transcript encoding a protein kinase family member. Cell 6g: 799–808

    Google Scholar 

  6. Cao A, Cianchetti C, Calisti L, De Virgilis S, Ferreli A, Tangheroni W (1978) Schwartz-Jampel Syndrome. Clinical. Electrophysiological and histopathological study of a severe variant. J Neurol Sci 35: 175–187

    PubMed  CAS  Google Scholar 

  7. Casanova G, Jerusalem F (1979) Myopathology of myotonic dystrophy. Acta Neuropathol 45: 231–240

    PubMed  CAS  Google Scholar 

  8. Dieler R, Schröder JM (1990) Lacunar dilatations of intrafusal and extrafusal terminal cisternae. annulate lamellae. Confronting cisternae and tuhulofilamentous inclusions within the spectrum of muscle and nerve fiher changes in myotonic dystrophy. Pathol Res Pract 186: 371–382

    PubMed  CAS  Google Scholar 

  9. Engel AG (1970) Evolution and content of vacuoles in primary hypokaliemic periodic paralysis. Mayo Clin Proc 45: 774–814

    PubMed  CAS  Google Scholar 

  10. Engel AG, Jerusalem F, Tsujihata M, Gomez MR (1974) The neuromuscularjunction in myopathies. A quantitative ultrastructural study. In: Recent advances in myology. Proceedings of the 3rd Intern Congr on Muscle Diseases, Newcastle upon Tyne, 15–21 Sept 1974. Excerpta Medica. Amsterdam. pp 132–143 (Int Congr Ser 360) Erkrankungen der Skelettmuskulatur

    Google Scholar 

  11. Franke CH, Iaizzo PA, Hatt H, Spittelmeister W, Ricker K, Lehmann- Horn F (1991) Altered Na+ channel activity and reduced Cl - conductance cause hyperexcitability in recessive generalized myotonia (Becker). Muscle Nerve 14: 762–770

    PubMed  CAS  Google Scholar 

  12. Heene R (1973) Histological and histochemical findings in muscle spindles in dystrophia myotonica. J Neurol Sci 18: 369–372

    PubMed  CAS  Google Scholar 

  13. Kuhn E (1969) Hereditäre Myopathien. In: Heilmeyer L, Miiller AF, Prader A, Schoen R (Hrsg) Ergebnisse der inneren Medizin und Kinderheilkunde, Bd 2. Springer, Berlin Heidelberg New York, S 188–290

    Google Scholar 

  14. Kuhn E, Fiehn W, Rüdel R, Schröder JM, Seiler D (1979) HerediUire und experimentelle Myotonie. Eine vergleichende Studie. N ervenarzt 50: 653–657

    CAS  Google Scholar 

  15. Kuhn E, Fiehn, W, Seiler D, Schröder JM (1979) The autsomal recessive (Becker) form of myotonia congenita. Muscle Nerve 2: 109–117

    PubMed  CAS  Google Scholar 

  16. Maynard JA, Cooper RR, Ionaescu VV (1977) An ultrastructure investigation of intrafusal muscle fibers in myotonic dystrophy. Virchows Arch [A] 373: 1–3

    CAS  Google Scholar 

  17. Pollock M, Dyck PJ (1976) Peripheral nerve morphometry in myotonic dystrophy. Arch Neurol33: 33–39

    Google Scholar 

  18. Resnick JS, Dormann JD, Engel WK (1969) Thyrotoxic periodic paralysis. Am J Med 47: 831

    PubMed  CAS  Google Scholar 

  19. Ricker K, Lehmann-Horn F, Moxley RT (1990) Myotonia fluctuans. Arch Neurol 47: 268–272

    PubMed  CAS  Google Scholar 

  20. Rosman NP, Rebeiz JJ (1967) The cerebral defect and myopathy in myotonic dystrophy. Neurology (Minneap) 17: 1106–1112

    CAS  Google Scholar 

  21. Schröder JM (1978) Vakuolisierte Muskelfasern bei Myotonien und periodischen Paralysen. In: Fortschritte der Myologie, Bd V. Gutenbergdruckerei, Freiburg, S 20–29

    Google Scholar 

  22. Schröder JM, Adams RD (1968) The ultrastructural morphology of the muscle fiber in myotonic dystrophy. Acta Neuropathol 10: 218–241

    PubMed  Google Scholar 

  23. Schröder JM, Becker PE (1972) Anomalien des T-Systems und des sarkoplasmatischen Reticulums bei der Myotonie, Paramyotonie und Adynamie. Virchows Arch [A] 257: 319–244

    Google Scholar 

  24. Walton IN, Irving D, Tomlinson BE (1977) Spinal cord limb motor neurons in dystrophia myotonica. J Neurol Sci 34: 199–211

    PubMed  CAS  Google Scholar 

  25. Zimmerli O, Moser H, Lattke F, v Matt B, Gerber H (1977) Die eugenische Bedeutung der Kopplung zwischen den Genloci für Dystrophia myotonica (M.Steinert) und ABH-Sekretor. Schweiz Med Wochenschr 107: 327–335

    PubMed  CAS  Google Scholar 

Literatur

  1. Bonilla E, Schotland DL (1970) Histochemical diagnosis of muscle phosphofructokinase deficiency. Arch Neurol 22: 8–12

    PubMed  CAS  Google Scholar 

  2. Carpenter S, Karpati G, Andcrmann F, Jacob JE, Andermann E (1974) Lafora’s diseases: peroxisomal storage in skeletal muscle. Neurology (Minneap) 24: 531–538

    CAS  Google Scholar 

  3. Cori GT (1957) Biochemical aspects of glycogen deposition disease. In: Hottinger A, Hauser F, Berger H, (eds) Modern problems in pediatrics, vol 3. Karger, Basel, pp 344–358

    Google Scholar 

  4. Eränkö O, Palkama A (1961) Improved localization of phosphorylase by the use of polyvinyl pyrrolidine and high substrate concentration. J Histochem Cytochem 9: 585

    PubMed  Google Scholar 

  5. Goebel HH, Shin YS, Gullotta F, Yokota T, Alroy J, Voit T, Haller P, Schulz A (1992) Adult polyglucosan body myopathy. J Neuropathol Exp Neurol 51: 24–35

    PubMed  CAS  Google Scholar 

  6. Gullotta F, Stefan H, Mattern H (1976) Pseudodystrophische Muskelglykogenose im Erwachsenenalter (Saure-Maltase-Mangel- Syndrom). J Neurol 213: 199–216

    PubMed  CAS  Google Scholar 

  7. Mehler M, DiMauro S (1976) Late-onset acid maltase deficiency. Detection of patients and heterozygotes by urinary enzyme assay. Arch Neurol 33: 692–695

    PubMed  CAS  Google Scholar 

  8. Neville HE, Brooke MH, Austin JH (1974) Studies in myoclonus epilepsy (Lafora body form). IV. Skeletal muscle abnormalities. Arch Neurol 30: 466–474

    PubMed  CAS  Google Scholar 

  9. Pearson CM (1968) Glycogen metabolism and storage diseases of types III. IV. Am J Clin Pathol 50: 29–43

    PubMed  CAS  Google Scholar 

  10. Rowland LP, Lovelace RE, Schotland DL, Araki S, Carmel P (1966) The clinical diagnosis of McArdle’s disease: Identification of another family with deficiency of muscle phosphorylase. Neurology (Minneap) 16: 93–100

    CAS  Google Scholar 

  11. Schröder JM, Dodel R, Weis J, Stefanidis I, Reichmann H (1995). Mitochondrial changes in muscle phosphoglycerate kinase deficiency. Clin Neuropathol (submitted)

    Google Scholar 

  12. Schröder JM, May R, Shin YS, Sigmund M, Nase-Hüpmeier S (1993) Juvenile hereditary polyglucosan body disease with complete brancher enzyme deficiency (type IV glycogenosis). Acta Neuropathol 85: 419–430

    PubMed  Google Scholar 

  13. Steinitz K (1967) Laboratory diagnosis of glycogen diseases. Adv Clin Chern 9: 227–354

    CAS  Google Scholar 

  14. Wilkinson DA, Tonin P, Shanske S, Lombes A, Carlson GM, Di Mauro S (1994) Clinical and biochemical features of 10 adult patients with muscle phosporylase kinase deficiency. Neurology 44:461–466

    PubMed  CAS  Google Scholar 

Literatur

  1. Bradley WG, Hudgson P, Gardner-Medwin D, Walton IN (1969) Myopathy associated with abnormal lipid metabolism in skeletal muscle. Lancet 1: 495–498

    PubMed  CAS  Google Scholar 

  2. Campos Y, Huerta R, Lorenzo G, Bautista J, Gutierrez E, Aparicio M, Alesso L, Arenas J (1993) Plasma carnitine insufficiency and effectiveness of L-carnitine therapy in patients with mitochondrial myopathy. Muscle Nerve 16: 150–153

    PubMed  CAS  Google Scholar 

  3. DeVries DO, Buzing CJM, Ruitenbeek W, van der Wouw MPME, Sperl W, Sengers RCA, Trijbels JMF, Van Oost BA (1992) Myopathology and a mitochondrial DNA deletion in the Pearson marrow and pancreas syndrome. Neurom Dis 2: 185–195

    CAS  Google Scholar 

  4. DiMauro S, DiMauro PMM (1973) Muscle carnitine palmityl transferase deficiency and myoglobinuria. Science 182: 929

    PubMed  CAS  Google Scholar 

  5. DiMauro S, Trevisan C, Hays A (1980) Disorders of lipid metabolism in muscle. Muscle Nerve 3: 269–288

    Google Scholar 

  6. Drachmann DA (1968) Ophthalmoplegia plus: The neurodegenerative disorders associated with progressive external ophthalmoplegia. Arch Neurol 18: 654–674

    Google Scholar 

  7. Engel WK (1971) “Ragged-red fibers” in ophthalmoplegia syndromes and their differential diagnosis. In: Abstracts of the 2nd International Congress on Muscle Diseases. Perth, November 22–26. Excerpta Medica, Amsterdam (Int Congr Ser 237)

    Google Scholar 

  8. Engel AG, Angelini C (1973) Carnitine deficiency of human skeletal muscle with associated lipid storage myopathy. Science 1979: 899–902

    Google Scholar 

  9. Fujä T, Okuno T, Ito M, Mutoh K, Horiguchi Y, Tashiro H, Mikaga H (1991) MELAS of infantile onset: mitochondrial angiopathy or cytopathy? J Neurol Sci 103: 37–41

    Google Scholar 

  10. Goebel HH, Zeman W, Pilz H (1975) Significance of muscle biopsies in neuronal ceroid-lipofuszinoscs. J Neurol Neurosurg Psychiatry 38: 985–993

    PubMed  CAS  Google Scholar 

  11. Gullotta F, Stefan H, Mattern H (1976) Pseudodystrophische Muskelglykogenose im Erwachsenenalter (Saure-Maltase-Mangel-Syndrom). J Neuro1 213: 199–216

    CAS  Google Scholar 

  12. Haginoya K, Miyabayashi S, Änuma K, Tada K (1990) Mosaicism of mitochondria in mitochondrial myopathy: an electron-microscopic analysis of cytochrome c oxidase. Acta Neuropathol 80: 642–648

    PubMed  CAS  Google Scholar 

  13. Hammans SR, Sweeney MG, Brockington M, Morgan-Hughes JA, Harding AE (1991) Mitochondrial encephalopathies: molecular genetic diagnosis from blood samples. Lancet 337: 1311–1313

    PubMed  CAS  Google Scholar 

  14. Hammersen F, Gidöf L, Larsson J, Lewis DH (1980) The occurrence of paracrystalline mitochondrial inclusions in normal human skeletal muscle. Acta Neuropathol 49: 35–41

    PubMed  CAS  Google Scholar 

  15. Harding AE (1991) Neurological disease and mitochondrial genes. Trends Neurosci 14: 132–13R

    PubMed  CAS  Google Scholar 

  16. Hirano M, Ricci E, Kocnigsberger MR, Defendini R, Pavlakis StG, DeVivo DC, DiMauro S, Rowland LP (1992) MELAS: an original case and clinical criteria for diagnosis. Neurom Dis 2: 125–135

    CAS  Google Scholar 

  17. Jerusalem F, Angelini C, Engel AG, Groover RV (1973) Mitochondrial-lipid-glycogen (MLG) disease of muscle. Arch Neurol 29: 162–169

    PubMed  CAS  Google Scholar 

  18. Kearns TP, Sayre GP (1958) Retinitis pigmentosa external ophthalmoplegia, and complete heart block: Unusual syndrome with histologic study in one of two cases. Arch Ophthalmol 60: 2RO

    Google Scholar 

  19. Kott E, Delpre G, Kadish U, Dziatelovski M, Sandbank U (1977) Abetaliproteinemia (Bassen-Kornzweig-Syndrome). Muscle involvement. Acta Neuropathol 37: 255–25S

    PubMed  CAS  Google Scholar 

  20. Mechler F, Fawcett PRW, Mastaglia FL., Hudgson P (1981) Mitochondrial myopathy. J Neurol Sci 50: 191–200

    PubMed  CAS  Google Scholar 

  21. Miranda A, DiMauro S, Eastwood A, Hays A, Johnson WG, Olartc M, Whitlock R, Mayeux R, Rowland LP (1979) Lipid storage myopathy. ichthyosis and steatorrhea. Muscle Nerve 2: 1–13

    PubMed  CAS  Google Scholar 

  22. Olson E, Engel WK, Walsh GO, Einaugler R (1972) Oculocraniosomatic neuromuscular disease with “ragged-red” fibers. Arch Neurol 26: 193–211

    PubMed  CAS  Google Scholar 

  23. Scholte HR, J ennekens FGI, Bouvy JJBJ (1979) Carnitine palmitoyltransferase Ä deficiency with normal carnitine palmitoyl-Erkrankungen der Skelettmuskulatur 435 transferase I in skeletal muscle and leucocytes. J Neurol Sci 40: 39–51

    PubMed  CAS  Google Scholar 

  24. Schröder JM (1994) Aging of skeletal muscle. S 485–498. In: Pathobiology of the Aging Rat. Vol. 2. Eds, Mohr U, Dungworth DL, Capen CC. ILSI Press Washington D. C.

    Google Scholar 

  25. Schröder JM, Thomas G, Reddemann R (1981) MyotubuHire Lipidspeicherungsmyopathie mit Verkalkungen: eine neue Variante kongenitaler Myopathien. In: Fortschritte der Myologie, Bd VI. Gutenbergdruckerei, Freiburg/Br, S 20–27

    Google Scholar 

  26. Schröder JM, Weber R, Weyhenmeyer S, Lammers-Reissing A, Meurers B, Reichmann H (1991) Adult onset lipid storage in gastric mucosa and skeletal muscle fibers associated with gastric pain, progressive muscle weakness and partial deficiency of cytochrome c oxidase. Pat hoi Res Pract 187: 85–95

    Google Scholar 

  27. Schröder JM (1993) Neuropathy associated with mitochondrial disorders. Brain Pathol 3: 177–190

    PubMed  Google Scholar 

  28. Shy GM, Gonatas NK, Perez M (1966) Two childhood myopathies with abnormal mitochondria. Part 1: Megaconial myopathy. Part 2: Pleoconial myopathy. Brain 89: 133–158

    PubMed  CAS  Google Scholar 

  29. Smeitink J, Stadhouders A, Sengers R, Ruitenbeek W, Wevers R, Ter Laak H, Trijbels F (1992) Mitochondrial creatine kinase containing crystals. Creatine content and mitochondrial creatine kinase activity in chronic progressive external ophthalmoplegia. Neurom Dis 3: 35–40

    Google Scholar 

  30. Tomé FMS, Fardeau M (1976) Ultrastructural study of a muscle biopsy in a case of GM 1 gangliosidosis type I. Pathol Europ 11: 15–25

    Google Scholar 

  31. Tomé FMS, Fardeau M, Lenoir G (1977) Ultrastructure of muscle and sensory nerve in Fabry’s disease. Acta Neuropathol 38: 187–194

    PubMed  Google Scholar 

  32. Weis J, Schröder JM (1988) Adult polyglucosan body myopathy with subclinical peripheral neuropathy. Case report and review of diseases with polyglucosan body accumulation. Clin Neuropathol 7:271–279

    PubMed  CAS  Google Scholar 

  33. Zeviani M, Antozzi C (1992) Defects of mitochondrial DNA. Brain Pathol 2: 121–132

    PubMed  CAS  Google Scholar 

  34. Zintz R (1966) Dystrophische Veränderungen in au/3eren Augenmuskeln und Schultermuskeln bei der sog. progressiven Graefeschen Ophthalmoplegie. In: Kuhn E, (Hrsg) Progressive Muskeldystrophie, Myotonie, Myasthenie. Springer, Berlin Heidelberg New York, S 109–151

    Google Scholar 

Literatur

  1. Araki M, Takagi A, Higuchi T, Sugita H (1988) Neuroleptic malignant syndrome: Caffeine contracture of single muscle fibers and muscle pathology. Neurology 38: 297–301

    PubMed  CAS  Google Scholar 

  2. Britt BA, Kalow W (1970) Malignant hyperthermia: A statistical review. Can Anaesth Soc J 17: 293–315

    PubMed  CAS  Google Scholar 

  3. Denborough MA, Lowell RRH (1960) Anesthetic death in a family. Lancet Ä: 45

    Google Scholar 

  4. Eng GD, Epstein BS, Engel WK, McKay DW, McKay R (1978) Malignant hyperthermia and central core disease in a child with congenital dislocating hips. Arch Neurol 35: 189–197

    PubMed  CAS  Google Scholar 

  5. Schmalbruch H (1979) A freeze-facture study of the plasma membrane of muscle fibres of a patient with chronic creatine kinase elevation suspected for malignant hyperthermia. J Neuropathol Exp Neurol 38: 407–418

    PubMed  CAS  Google Scholar 

  6. Wedel DJ (1992) Malignant hyperthermia and neuromuscular disease. Neurom Dis 2: 157–164

    CAS  Google Scholar 

Literatur

  1. Azmy A, Bensted JPM, Eckstein HB (1979) Myositis ossificans progressiva. Z Kinderchir 26: 252–258

    Google Scholar 

  2. Enzinger FM, Weiss SW (1983) Soft tissue tumors. Mosby, St Louis Toronto London

    Google Scholar 

  3. Kawai H, Sebe T, Nishino H, Nishida Y, Saito S (1991) Light and electron microscopic studies on localization of myoglobin in skeletal muscle cells in neuromuscular diseases. Muscle Nerve 14: 342–347

    PubMed  CAS  Google Scholar 

  4. Lagier R, Cox IN (1975) Pseudomalignant myositis ossificans. A pathological study of eight cases. Hum Pathol 6: 653–665

    PubMed  CAS  Google Scholar 

Literatur

  1. Bestetti G, Zemp C, Probst D, Rossi GL (1981) Neuropathy and myopathy in the diaphragma of rats after 12 months of streptozotocin-induced diabetes mellitus. A light-, electron microscopic and morphometric study. Acta Neuropathol 55: 11–20

    PubMed  CAS  Google Scholar 

  2. Clark AF, Vignos PJ (1979) Experimental corticosteroid myopathy: Effect on myofibrillar ATPase activity and protein degradation. Muscle Nerve 2: 265–273

    PubMed  CAS  Google Scholar 

  3. Hanzlikova V, Gutman E (1978) Effect of castration and testosterone administration on the neuromuscular junction in the levator ani muscle of the rat. Cell Tiss Res 189: 155–166

    CAS  Google Scholar 

  4. McKeran RO, Slavin G, Ward P, Paul E, Mair WGP (1980) Hypothyroid myopathy. A clinical and pathological study. J Pathol 132: 35–54

    PubMed  CAS  Google Scholar 

  5. Patten GM, Bilezikian JP, Mallette LE, Price A, Engel WK, Aurbach GD (1974) Neuromuscular disease in primary hyperparathyreoidism. Ann Intern Med 80: 182–193

    PubMed  CAS  Google Scholar 

Literatur

  1. Pleasure DE, Walsh GO, Engel WK (1970) Atrophy of skeletal muscle in patients with Cushing’s syndrome. Arch Neurol 22: 118–125

    PubMed  CAS  Google Scholar 

  2. Schroder JM, Kramer G, Rothmund M, Hopf HC (1981) Selektive Kalksalzablagerungen in der motorischen Endplatte bei Hyperparathyreoidismus. Acta Neurol 8: 124–126

    Google Scholar 

  3. Vassilopoulos D, Lumb EM, Corrall RJM, Emery AEH (1976) Muscle karyometry in diabetic neuropathy. J NeuroI 213: 257–261

    CAS  Google Scholar 

  4. Weis J, Dimpfel W, SchrOder JM (1995) Nerve conduction changes and fine structural alterations of extra- and intrafusal muscle and nerve fibers in streptozotocin diabetic rats. Muscle Nerve 18: 175–184

    PubMed  CAS  Google Scholar 

  5. Clouston PD, Saper CB, Arbizu T, Johnston I, Lang B, NewsomDavis J, Posner JB (1992) Paraneoplastic cerebellar degeneration. III. Cerebellar degeneration, cancer, and the Lambert-Eaton myasthenic syndrome. Neurology 42: 1944–1950

    PubMed  CAS  Google Scholar 

Literatur

  1. Faris AA, Reyes MG (1971) Reappraisal of alcoholic myopathy. J Neurol Neurosurg Psychiatry 34: 86–92

    PubMed  CAS  Google Scholar 

  2. Hed R, Lundmark C, Fahlgren H, Oneil S (1962) Acute muscular syndrome in chronic alcoholism. Acta Med Scand 171: 585–599

    PubMed  CAS  Google Scholar 

  3. Juntunen J, Teräväinen H, Eriksson K, Larsen A, Hillbom M (1979) Peripheral neuropathy and myopathy. An experimental study of rats on alcohol and variable dietary thiamine. Virchows Arch A Path Anat Histol 383: 241–252

    CAS  Google Scholar 

  4. Lambert EH, Eaton LM, Rooke ED (1956) Defect ofneuromuscular conduction associated with malignant neoplasms. Am J Physiol 187: 612–613

    Google Scholar 

  5. Rosman NP, Schapiro MB, Haddow JE (1978) Muscle weakness caused by an iodine-deficient diet: investigation of a nutritional myopathy. J Neuropathol Exp Neurol 2: 192–211

    Google Scholar 

  6. Shy GM, Silverstein I (1965) A study of the effects upon the motor unit by remote malignancy. Brain 88: 515–528

    PubMed  CAS  Google Scholar 

  7. Urich H, Wilkinson M (1970) Necrosis of muscle with carcinomas: myositis or myopathy? J Neurol Neurosurg Psychiatry 33: 398–407

    PubMed  CAS  Google Scholar 

Literatur

  1. Lane RJM, Mastaglia FL (1978) Drug-induced myopathies in man. Lancet 3: 562–565

    Google Scholar 

Download references

Authors
  1. J. M. Schröder
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Kliniken der Landeshauptstadt, Institut für Pathologie, Ludwig-Erhard-Straße 100, 65199, Wiesbaden, Germany

    Wolfgang Remmele

  2. Institut für Hirnforschung der Universität Tübingen, Calwerstraße 3, 72076, Tübingen, Germany

    Jürgen Peiffer

  3. Institut für Neuropathologie der Medizinischen Fakultät der RWTH Aachen, Pauwelsstraße 30, 52057, Aachen, Germany

    J. Michael Schröder

Rights and permissions

Reprints and permissions

Copyright information

© 1995 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Schröder, J.M. (1995). Pathologie der Skelettmuskulatur. In: Remmele, W., Peiffer, J., Schröder, J.M. (eds) Pathologie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-85179-7_22

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-85179-7_22

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-85180-3

  • Online ISBN: 978-3-642-85179-7

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation